Oncology Letters

1792-1074 1792-1082

D.A. Spandidos

10.3892/ol.2021.13002

OL-0-0-13002

Corrigendum

MicroRNA-100 functions as a tumor suppressor in cervical cancer via downregulating the SATB1 expression and regulating AKT/mTOR signaling pathway and epithelial-to-mesenchymal transition

Huang

Cuiping

Qin

Xiaobo

Zhao

Jin

Huijing

Zhang

Shuangjun

Yang

Haiyan

10 2021

17 08 2021

22 4

741

2021

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Oncol Lett 20: 1336-1344, 2020; DOI: 10.3892/ol.2020.11686

Subsequently to the publication of the above article, an interested reader drew to the authors’ attention that a section of the data shown in Fig. 1C (Transwell assay data for HeLa cells), the “miR-100 inhibitor” panel appeared to be overlapping with the “miR-100 inhibitor” panel featured in Fig. 1D (showing the Transwell assay data for Ca-Ski cells).

The authors have checked their original data, and realized that the incorrect data were inadvertently selected for the “miR-100 inhibitor” panel in Fig. 1D. A corrected version of Fig. 1, including the correct data for Fig. 1D, is shown below. The authors are grateful to the Editor of Oncology Letters for granting them the opportunity to publish this corrigendum, and regret any inconvenience caused to the readership of the Journal.

Figure 3.

miR-100 restoration significantly represses CC cell invasion and migration. (A and B) The invasion and migration abilities of HeLa cells treated with miR-100 mimics were assessed by Transwell assays. (C and D) Transwell assay was performed to determine the invasion and migration capacities of Ca-Ski cells treated with miR-100 inhibitor. **P<0.01 and ***P<0.001. CC, cervical cancer.